Clinical trial
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe…
NCT00004419 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00004419 |
|---|---|
| Title | Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Insulin Resistance, Hyperglycemia |
| Intervention type | Drug |
| Interventions | insulin-like growth factor I |
| Enrollment | 18 |
| Start date | Apr 1, 1998 |
| Completion | Sep 1, 2000 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: